Enzymatic cycling comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-08-19. Numbers and descriptions here follow the published literature rather than marketing material.
Solid NAD+ is usually supplied as a white to off-white powder or lyophilized preparation. It is hygroscopic and should be kept desiccated at low temperature, commonly -20 °C or below for long-term storage. Aqueous solutions are less stable than dry material and are often prepared fresh or stored frozen in aliquots. Light exposure and repeated freeze-thaw cycles can promote degradation, so amber containers and single-use aliquots are preferred. Buffered solutions near neutral pH are generally less stable than acidic or frozen preparations.
Quantification of NAD+ in biological samples typically uses liquid chromatography coupled to mass spectrometry. Enzymatic cycling assays offer higher throughput and rely on NAD+ dependent dehydrogenases to amplify signal. Both approaches require careful sample quenching because NAD+ can be rapidly consumed or converted after collection. Acidic extraction is common for NAD+, while alkaline conditions favor NADH in some protocols. Isotopically labeled internal standards help correct for losses during extraction and ionization.
Commercial NAD+ is available at research grade, often with purity specifications determined by high-performance liquid chromatography. Certificates of analysis may report water content, residual solvents, and counterion identity. Identity can be confirmed by ultraviolet absorbance near 260 nm, mass spectrometry, or enzymatic activity. Because different salt forms and hydration states exist, researchers should verify that the product matches the intended molecular form. Lot-to-lot variation in purity can affect quantitative assays and should be documented.
Nicotinamide adenine dinucleotide, abbreviated NAD+, is a dinucleotide built from adenine, nicotinamide, two ribose sugars, and two phosphate groups. The oxidized form carries a positive charge on the nicotinamide ring, while the reduced form, NADH, is neutral. This pair acts as a reversible electron carrier in cells. NAD+ is present in bacteria, plants, animals, and fungi. Its structure allows it to accept and donate electrons without being consumed in the reactions it supports.
In redox reactions, NAD+ accepts a hydride ion, which consists of two electrons and one proton. The hydride adds to the nicotinamide ring at a specific carbon, converting NAD+ into NADH. Dehydrogenase enzymes use this step in glycolysis, the citric acid cycle, and fatty acid oxidation. NADH later donates electrons to the mitochondrial electron transport chain, helping to drive ATP synthesis. The balance between NAD+ and NADH reflects the metabolic state of a cell, and shifts in that balance can alter how pathways operate.
| Property | Value | Notes |
|---|---|---|
| Solubility | Freely soluble in water | Forms acidic solution; salt form may alter solubility |
| Typical storage temperature | -20 °C or lower | Desiccated and protected from light |
| Common analytical method | LC-MS | Used for biological quantification |
| UV absorbance maximum | 260 nm | Aqueous solution; pH dependent |
| Common synonym | Diphosphopyridine nucleotide | Older name abbreviated DPN |
Purified NAD+ is typically supplied as a white to off-white powder and stored desiccated at low temperature. Airtight containers limit moisture uptake, while protection from light reduces degradation of the nicotinamide ring. Aqueous stock solutions are less stable than solid material and are often aliquoted before freezing. Repeated freeze-thaw cycles can lower integrity, so working portions are kept separate. Purity is commonly checked by ultraviolet absorbance near 260 nm, high-performance liquid chromatography, or mass spectrometry.
Stability studies show that NAD+ can hydrolyze under prolonged heat, extreme pH, or microbial contamination. Phosphate buffers near neutral pH are often used for short-term handling, though exact stability depends on concentration, temperature, and matrix. In biological samples, endogenous enzymes can rapidly degrade NAD+, making cold chain and fast processing important. Analytical reports should state extraction conditions, internal standards, and validation parameters. Without those details, comparisons across studies remain difficult and potentially misleading.
In humans, NAD+ can be synthesized from nicotinic acid, nicotinamide, nicotinamide riboside, and tryptophan through overlapping pathways. The salvage pathway recycles nicotinamide back to NAD+ and is often considered a major route in many tissues. Dietary precursors and intracellular recycling both contribute to the pool, but the quantitative importance of each source remains an active research question. NAD+ levels are not uniform across organs or cell compartments. Measurements in blood do not necessarily reflect concentrations inside tissues.
NAD+ is a dinucleotide composed of nicotinamide, ribose, and adenine linked by phosphate groups. Its full name is nicotinamide adenine dinucleotide, with "+" denoting the oxidized form. The molecule acts as a coenzyme in redox reactions, cycling between NAD+ and NADH. In cells, it participates in electron transfer during glycolysis, the citric acid cycle, and oxidative phosphorylation. It is distinct from NADP+, which carries an additional phosphate group and supports different biosynthetic reactions.
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that transfer ADP-ribose or remove acetyl groups. Sirtuins, PARPs, and CD38-family enzymes consume NAD+ and produce nicotinamide and ADP-ribose-related products. These reactions link NAD+ availability to DNA repair, chromatin modification, and cellular signaling. Because the molecule is central to energy metabolism and regulation, changes in its concentration are studied in aging, immunity, and metabolic research. The balance between synthesis and consumption varies by tissue, developmental stage, and physiological state.
Cells produce NAD+ through several biosynthetic routes. The salvage pathway recycles nicotinamide, while the Preiss-Handler pathway uses nicotinic acid, and a de novo route can start from tryptophan in some organisms. In mammals, the salvage pathway is generally considered the main source under ordinary conditions. Tissue concentrations vary widely by cell type and compartment, and measured declines with age have been reported in some studies. Whether such changes drive aging or mainly accompany it remains an open question.
Nicotinamide adenine dinucleotide, commonly abbreviated NAD+, is a coenzyme present in all living cells. The molecule consists of two nucleotides linked by phosphate groups, with adenine and a nicotinamide ring as its principal features. In its oxidized form, the nicotinamide ring can accept a hydride ion, becoming NADH. This reversible conversion places NAD+ at the center of many electron-transfer reactions. Its role as a redox carrier is well established across bacteria, plants, fungi, and animals.
However, comparisons with supervolcanoes are more misleading than helpful due to the different aerosols released, the likely air burst fuzing height of nuclear weapons and the globally scattered location of these potential nuclear detonations all being in contrast to the singular and subterranean nature of a supervolcanic eruption. Moreover, assuming the entire world stockpile of weapons were grouped together, it would be difficult, due to the nuclear fratricide effect, to ensure the individual weapons would go off all at once. Nonetheless, many people believe that a full-scale nuclear war would result, through the nuclear winter effect, in the human extinction, though not all analysts agree on the assumptions that underpin these nuclear winter models. On 26 September 1983, a Soviet early warning station under the command of Stanislav Petrov falsely detected 5 inbound intercontinental ballistic missiles from the US. Petrov correctly assessed the situation as a false alarm, and hence did not report his finding to his superiors. It is quite possible that his actions prevented "World War III", as the Soviet policy at that time was immediate nuclear response upon discovering inbound ballistic missiles. The world came unusually close to nuclear war in November 1983 when the Soviet Union thought that the NATO military exercise Able Archer 83 was a ruse or "cover-up" to begin a nuclear first strike. The Soviets responded by raising readiness and preparing their nuclear arsenal for immediate use. Soviet fears of an attack ceased once the exercise concluded without incident.
Russ Prize "for automating DNA sequencing that revolutionized biomedicine and forensic science"; the 2011 National Medal of Science, presented at a White House ceremony by President Obama in early 2013; the IEEE Medal for Innovations in Healthcare Technology in 2014, and the 2016 Ellis Island Medal of Honor. In 2017 he received the NAS Award for Chemistry in Service to Society. In 2019 Hood was awarded the IRI Medal, established by the Industrial Research Institute (IRI).
=== Extraction for treatment === Extracted growth hormone was used since the late 1950s until the late 1980s when its use was replaced by recombinant GH. In the late 1950s, Maurice Raben purified enough GH from human pituitary glands to successfully treat a GH-deficient boy. A few endocrinologists began to help parents of severely GH-deficient children to make arrangements with local pathologists to collect human pituitary glands after removal at autopsy. Parents would then contract with a biochemist to purify enough growth hormone to treat their child. Few families could manage such a complicated undertaking. In 1960, the National Pituitary Agency was formed as a branch of the U.S. National Institutes of Health. The purpose of this agency was to supervise the collection of human pituitary glands when autopsies were performed, arrange for large-scale extraction and purification of GH, and distribute it to a limited number of pediatric endocrinologists for treating GH-deficient children under research protocols. Canada, UK, Australia, New Zealand, France, Israel, and other countries establish similar government-sponsored agencies to collect pituitaries, purify GH, and distribute it for treatment of severely GH-deficient children. Supplies of this "cadaver growth hormone" were limited, and only the most severely deficient children were treated. From 1963 to 1985 about 7,700 children in the U.S. and 27,000 children worldwide were given GH extracted from human pituitary glands to treat severe GH deficiency.
Sources: en.wikipedia.org
=== No development reported === AD-6626 – aldehyde dehydrogenase 2 (ALDH2) inhibitor – alcoholism AM-6527 (AM6527) – cannabinoid CB1 receptor antagonist – substance-related disorders Amitifadine (DOV-21947; EB-1010) – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) – alcoholism, opioid-related disorders, smoking withdrawal, substance-related disorders Arbaclofen extended release – GABAB receptor agonist – opioid-related disorders BMB-101 – serotonin 5-HT2 receptor agonist – opioid-related disorders Bupropion/mecamylamine (INT-0003; QuitPak) – combination of bupropion (norepinephrine–dopamine reuptake inhibitor (NDRI), nicotinic acetylcholine receptor negative allosteric modulator) and mecamylamine (non-selective nicotinic acetylcholine receptor antagonist) – smoking withdrawal Cannabidiol (CBD; cannabidiol transderma/topical gel/patch; Zygel; ZYN-002) – cannabinoid/various actions – alcoholism, substance-related disorders CM-1212 – undefined mechanism of action – alcoholism, substance-related disorders CPP-115 – GABA transaminase (GABA-T) inhibitor – substance-related disorders CT-044 analogues - CERSCI Therapeutics – reactive oxygen species (ROS) inhibitors (CT-044 analogues) – opioid-related disorders CX-717 (CX717) – AMPA receptor positive allosteric modulator (ampakine) – substance-related disorders Cyproheptadine/prazosin (KT-110; Periactine/Alpress) – combination of cyproheptadine (various actions) and prazosin (α1-adrenergic receptor antagonist) – substance-related disorders DCR-AUD (DCR-A1203; NN-6020) – aldehyde dehydrogenase 2 (ALDH2) inhibitor, RNA interference – alcoholism Dimethyltryptamine (DMT; EBRX-101) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – smoking withdrawal GLWL-01 – ghrelin O-acyltransferase (GOAT) inhibitor – alcoholism GSK-598809 (GSK598809) – dopamine D3 receptor antagonist – smoking withdrawal, substance-related disorders GSK-1521498 – μ-opioid receptor inverse agonist – cocaine-related disorders GTS-21 (DMXB-A; DMBX-anabaseine) – nicotinic acetylcholine receptor agonist – smoking withdrawal Icalcaprant (ABBV-1354; CVL-354) – κ-opioid receptor antagonist – substance-related disorders Levodopa (CVT-301; CXG-89; Inbrija) – dopamine precursor (non-selective dopamine receptor agonist) – smoking withdrawal Mazindol controlled release (NLS-0; NLS-1; NLS-10; NLS-13; NLS-2; Nolazol; Quilience) – serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI) – opioid-related disorders Midomafetamine (MDMA; ecstasy) – serotonin–norepinephrine–dopamine releasing agent (SNDRA), serotonin 5-HT2 receptor agonist, and entactogen – substance-related disorders Mifepristone (C-1073; Corlux; Corluxin; Korlym; Mifegyne; Mifeprex; RU-38486; RU-486) – glucocorticoid, progesterone, and androgen receptor antagonist – smoking withdrawal Modafinil oral (ASB) – atypical dopamine reuptake inhibitor (DRI) – cocaine-related disorders Naloxone nasal spray (-12; LT-20; LT-21; LT-22; Naloxon B; Narcan Nasal Spray; OPNT-001) – μ-opioid receptor antagonist – cocaine-related disorders, substance-related disorders Nalmefene implant (nalmefene six-month implant) – μ-opioid receptor antagonist, κ-opioid receptor weak partial agonist – opioid-related disorders Naloxone buccal/intransal gel (Exonal) – opioid receptor antagonist – opioid-related disorders Nicotine abuse vaccine (Niccine) – nicotinic acetylcholine receptor agonist – smoking withdrawal Nicotine/cannabidiol chewing gum (nicotine/CBD; CVSI-007) – combination of nicotine (nicotinic acetylcholine receptor agonist) and cannabidiol (CBD) (cannabinoid/various actions) – smoking withdrawal Noribogaine derived therapeutic – various actions (noribogaine derivative) – opioid-related disorders OMS-405 (OMS405) – PPARγ agonist – alcoholism Ondansetron (AD-04) – serotonin 5-HT3 receptor antagonist – opioid-related disorders, smoking withdrawal Ondansetron/topiramate (AD-01; AD/TO-01) – combination of ondansetron (serotonin 5-HT3 receptor antagonist) and topiramate (various actions) – alcoholism Ondelopran (LY-2196044; Odelepan; Odelepran; OpRA) – opioid receptor antagonist – alcoholism OPNT-005 (OPNT005; adjuvanted heroin analogue vaccine; diamorphine analogue vaccine; heroin vaccine) – immunostimulant (vaccine against heroin) – heroin-related disorders PF-5402536 (NIC7-001; PF-5402536) – immunostimulant (smoking vaccine) – smoking withdrawal Pomaglumetad methionil (DB103; LY-2140023; LY-2812223; LY-404039 prodrug) – metabotropic glutamate mGlu2 and mGlu3 receptor receptor agonist (pomaglumetad prodrug) – substance-related disorders PPL-103 – μ-opioid receptor agonist, δ-opioid receptor agonist, κ-opioid receptor agonist – substance-related disorders Pregnenolone methyl ether (3β-methoxypregnenolone; MAP-4343) – microtubule-associated protein (MAP) stimulant and tubulin polymerization promoter – substance-related disorders Psilocybin (MYCO-001; MYCO-003) – non-selective serotonin receptor agonist, serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – substance-related disorders PT-150 (PT150; ORG-34517; SCH-900636) – androgen and glucocorticoid receptor antagonist – alcoholism Research programme: alcoholism therapeutics - ADial Pharmaceuticals – various actions – alcoholism Research programme: allosteric modulators - Addex Therapeutics – various actions – substance-related disorders Research programme: GPCR modulators - Nxera Pharma – various actions – cocaine-related disorders, substance-related disorders Research programme: nociceptin receptor agonists - Astraea Therapeutics – nociceptin receptor agonist, opioid receptor agonist – alcoholism, substance-related disorders Research programme: smoking cessation therapies - Ophidion – smoking withdrawal – nicotinic acetylcholine receptor agonists Research programme: tryptamine based therapeutics - PsyBio Therapeutics – serotonin 5-HT2A receptor agonists – substance-related disorders RTI-598929 – μ-opioid receptor antagonist and κ-opioid receptor antagonist – heroin-related disorders Saracatinib (AZD-0530) – Src-family kinase inhibitor – alcoholism SBP-9330 – metabotropic glutamate mGlu2 receptor modulator – smoking withdrawal SEL-068 (tSVP; immunomodulatory nanoparticle vaccine for smoking cessation) – immunomodulator (smoking vaccine) – smoking withdrawal Serdexmethylphenidate (KP-484; KP-1077; KP-1077H; KP-1077IH; KP-1077N; KP-879) – norepinephrine–dopamine reuptake inhibitor (NDRI) (dexmethylphenidate prodrug) – substance-related disorders TRV-734 (TRV734) – μ-opioid receptor biased agonist – opioid-related disorders VDM-001 – opioid receptor antagonist – alcoholism, opioid-related disorders Zolunicant (18-methoxycoronaridine; 18-MC; MM-110) – α3β4 nicotinic acetylcholine receptor antagonist – substance-related disorders
Boris Savinkov, leader of the organization Phlegont Klepikov, secretary and treasurer Colonel Alexander Perkhurov, chief of staff Colonel Karl Gopper, head of military personnel Colonel Stradetsky, liaison with the Volunteer Army Colonel Friedrich Briedis, responsible for intelligence, counterintelligence, and anti-Bolshevik propaganda among the Latvian Riflemen Doctor Aksanin (Nikolai Sergeyevich Grigoryev), head of the provincial and propaganda section Captain Alexander Vilenkin, head of the cavalry center Captain Schroeder, head of the artillery center Alexander Dikgof-Derenthal, who helped maintain contact with foreign missions Lyubov Dikgof, secretary to Savinkov
Major historical events of the Russian Partition included the Warsaw Uprising (1794) soon after Kościuszko's victory at Racławice. It ended up in the massacre of Praga district of Warsaw, in which the Russian imperial army killed up to 20,000 civilians in reprisal or revenge, regardless of gender and age. "The whole of Praga was strewn with dead bodies, blood was flowing in streams" wrote Suvorov himself. In 1807, the victorious Napoleon formed the Duchy of Warsaw after his War of the Fourth Coalition against Prussia and Russia. The new Duchy was held in personal union by King Frederick Augustus I of Saxony. However, the Duchy was dissolved after just a few years following the 1815 Congress of Vienna, and all its territory returned to its previous rulers. The Tsarist Kingdom of Poland was established in the territory returned to Russia with the Tsar taking the title of King of Poland. The protectorate was gradually integrated into Russia over the course of the 19th century. Notwithstanding, the relentless Russian exploitation activities led to the 1830–1831 November Uprising which took place in the heartland of partitioned Poland, forming a government. Its subsequent defeat resulted in a new wave of Tsarist mass repressions and punitive actions. In 1863–1864 another insurrection, the January Uprising, broke out. This time, the Carmelite friars who helped the insurgents were sent on death marches to Siberia chained by their necks together. The January Uprising lead to the Kingdom's autonomy being drastically reduced, and its renaming as Vistula Land.
== Production == The major industrial synthesis involves the reaction of sulfur trioxide and sulfur dichloride. This synthesis can be adapted to the laboratory by heating oleum to slowly distill the sulfur trioxide into a cooled flask of sulfur dichloride.
Sources: en.wikipedia.org
Southern: The southern section runs from the New River and consists of the prolongation of the Blue Ridge Mountains, which is divided into the Western Blue Ridge (or Unaka) Front and the Eastern Blue Ridge Front, the Ridge-and-Valley Appalachians, and the Cumberland Plateau. This same plateau is known as the Cumberland Plateau in southern West Virginia, eastern Kentucky, far Southwest Virginia, eastern Tennessee, and northern Alabama.
The enzyme glycerol kinase is present mainly in the liver and kidneys, but also in other body tissues, including muscle and brain. In adipose tissue, glycerol 3-phosphate is obtained from dihydroxyacetone phosphate with the enzyme glycerol-3-phosphate dehydrogenase.
== Flow control == There are various ways to control the fluid flow in the channels. They include changing the channel width and length, altering the wettability of the paper, diverting some fluid through a parallel channel, or changing the viscosity of the fluid. The flow in PADs can be turned off with dissolvable sugar bridges, Corona discharge treatment to alter a coating on the paper from a hydrophobic to hydrophilic state, or the use of an expandable polymer triggered by the flow to close the flow path.
=== Todd Barber === Todd Barber (Branden Cook) is Harper's ex-boyfriend from New York. The two remain sexually involved after their breakup, and he helps her forge her university transcripts when she is hired to Pierpoint. Todd later visits Harper in London; the two have a fight after Harper discovers he stole an expensive jacket from a patron at the nightclub they went to, where Todd calls Harper a coward and a hypocrite. Harper cuts ties with him for good.
Nondeletion forms: These defects, in general, involve a single base-pair substitution or small insertions near or upstream of the HBB gene. Deletion forms: base-pair deletions of different sizes involving the HBB gene produce syndromes such as hereditary persistence of fetal hemoglobin syndrome. Mutations are characterized as (βo) if they prevent any formation of β globin chains, and mutations are characterized as (β+) if they allow some β globin chain formation to occur.
Sources: en.wikipedia.org
Aqueous NAD+ solutions are best kept frozen in aliquots and protected from light. Repeated freezing and thawing is avoided because it can accelerate breakdown. Dry powder stored desiccated at -20 °C or lower typically remains stable for longer periods.
Liquid chromatography-mass spectrometry provides sensitive and specific quantification in cells and tissues. Enzymatic cycling assays are also widely used for plate-based measurement. Both methods need rapid sample processing to prevent post-collection changes.
Purity refers to the proportion of the intended dinucleotide relative to related nucleotides, salts, and water. A high-purity grade supports reproducible enzymatic assays. Researchers often check purity by chromatographic and spectroscopic methods before use.
It indicates the oxidized form, which has a positive charge on the nicotinamide nitrogen. The reduced partner NADH lacks that charge and carries added electrons. The plus sign is part of the standard abbreviation, not a separate ion.